MARLENE ERMIS: Open Payments
NPI 1306492145 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 28 payments from 7 companies in 2025. Trend: 2023 $44 · 2024 $0 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $105 |
| Lilly USA, LLC | 5 | $83 |
| PFIZER INC. | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Dexcom, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 5 | $23 |
Products named: MOUNJARO, Rybelsus, NURTEC ODT, Kerendia, Dexcom G6 Transmitter, TRELEGY ELLIPTA, VOQUEZNA, Ozempic.
Industry payments across TX — which companies pay providers there.
